Clinical Trials on Epilepsies, Myoclonic in Canada
Total 59 results
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
King's College LondonKing's College Hospital NHS Trust; Charles University, Czech Republic; Hopital... and other collaboratorsRecruitingJuvenile Myoclonic EpilepsyUnited States, Canada, Czechia, Denmark, Estonia, France, Italy, Norway, United Kingdom
-
UCB PharmaCompletedUnverricht-Lundborg DiseaseUnited States, Canada, Finland, France, Israel, Russian Federation, Serbia, Tunisia
-
University Health Network, TorontoZogenix, Inc.Not yet recruiting
-
Eisai Inc.RecruitingEpilepsies, MyoclonicUnited States, Canada
-
Zogenix International Limited, Inc., a subsidiary...CompletedDravet SyndromeUnited States, France, United Kingdom, Canada, Germany, Netherlands, Spain
-
Zogenix International Limited, Inc., a subsidiary...CompletedDravet SyndromeUnited States, United Kingdom, Spain, Belgium, Italy, Australia, Denmark, Germany, Canada, Japan, Netherlands, France
-
EpygenixForest Hills Lab; Liberyx TherapeuticsRecruitingDravet SyndromeUnited States, Canada, Spain, Georgia, Hungary
-
Zogenix International Limited, Inc., a subsidiary...CompletedDravet Syndrome | Seizure DisorderUnited States, United Kingdom, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Spain
-
TakedaCompletedDravet Syndrome (DS)China, Canada, France, Hungary, Poland, United States, Spain, Greece, Australia, Brazil, Serbia, Germany, Italy, Japan, Latvia, Netherlands, Ukraine, Russian Federation
-
Élise DuchesneFondation du Grand défi Pierre LavoieCompletedMyotonic Dystrophy 1Canada
-
Université du Québec à ChicoutimiRecruitingMyotonic Dystrophy Type 1 (DM1)Canada
-
Université de SherbrookeRare Disease FoundationCompletedMyotonic Dystrophy 1Canada
-
Cynthia GagnonFondation du Grand défi Pierre LavoieCompletedEffects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1Myotonic Dystrophy 1Canada
-
McMaster UniversityCompletedMuscular Dystrophies | Myotonic Dystrophy 1Canada
-
TakedaOvid Therapeutics Inc.CompletedEpilepsy | Dravet Syndrome | Lennox-Gastaut SyndromeUnited States, Canada, Israel, Poland, Spain, Australia, China, Portugal
-
McMaster UniversityNot yet recruiting
-
Taro Pharmaceuticals USATerminated
-
University of CalgaryRecruiting
-
TakedaActive, not recruitingEpilepsy | Dravet Syndrome (DS) | Lennox-Gastaut Syndrome (LGS)United States, Canada, Australia, China, Israel, Poland, Spain, Portugal
-
PepGen IncRecruitingMyotonic Dystrophy 1United States, Canada
-
Vertex Pharmaceuticals IncorporatedRecruitingMyotonic Dystrophy Type 1 (DM1)United Kingdom, Canada
-
TakedaRecruitingLennox Gastaut Syndrome (LGS) | Dravet Syndrome (DS)United States, China, Spain, France, Belgium, Australia, Brazil, Canada, Germany, Greece, Hungary, Italy, Japan, Latvia, Netherlands, Poland, Serbia, Mexico, Russian Federation, Ukraine
-
Zogenix, Inc.Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.Active, not recruitingDravet Syndrome | Epileptic Encephalopathy | Lennox Gastaut SyndromeUnited States, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Mexico, Netherlands, Poland, Spain, Sweden, United Kingdom
-
Virginia Commonwealth UniversityUniversity of Western Ontario, Canada, Children's Health Research Institute; Fondazione Serena Onlus - Centro Clinico NeMO MilanoRecruitingCongenital Myotonic DystrophyUnited States, Italy, Canada
-
The Hospital for Sick ChildrenCompletedPartial Epilepsy | Localization-related EpilepsyCanada
-
Lawson Health Research InstituteUCB Pharma GmbHTerminated
-
Laval UniversityCompleted
-
University of CalgaryUniversity of Alberta; University of Toronto; University of Western Ontario,... and other collaboratorsTerminatedTemporal Lobe EpilepsyCanada
-
Virginia Commonwealth UniversityRadboud University Medical Center; University of California, Los Angeles; University... and other collaboratorsRecruitingMyotonic Dystrophy 1United States, Netherlands, United Kingdom, New Zealand, Germany, Italy, Canada, France
-
Université de SherbrookeCentre de recherche du Centre hospitalier universitaire de Sherbrooke; Interdisciplinary... and other collaboratorsEnrolling by invitationUrinary Incontinence | Myotonic Dystrophy Type 1Canada
-
Sunnybrook Health Sciences CentreOttawa Hospital Research Institute; Institute for Clinical Evaluative SciencesActive, not recruitingCardiovascular Diseases | Sleep Apnea Syndromes | Cancer | Mortality | Sleep Initiation and Maintenance Disorders | Hospitalizations | Nocturnal Myoclonus SyndromeCanada
-
AMO Pharma LimitedCompletedCongenital Myotonic DystrophyUnited States, Canada, New Zealand, Australia, United Kingdom
-
Harmony Biosciences, LLCActive, not recruitingMyotonic Dystrophy 1 | Excessive Daytime SleepinessUnited States, Canada
-
AMO Pharma LimitedRecruitingCongenital Myotonic DystrophyUnited States, Canada, Australia, New Zealand
-
Cyberonics, Inc.TerminatedEpilepsy | Partial EpilepsyCanada, Spain, Belgium, France, Germany, Italy, Netherlands, Norway, Sweden, United Kingdom
-
NYU Langone HealthThe Epilepsy Study ConsortiumCompleted
-
Xenon Pharmaceuticals Inc.Novotech Health Holdings Pte. Ltd.Active, not recruitingFocal EpilepsySpain, United States, Ukraine, Canada, United Kingdom, Germany, Georgia, Italy, Moldova, Republic of
-
King's College LondonKing's College Hospital NHS Trust; The Hospital for Sick Children; Cardiff University and other collaboratorsCompletedRolandic EpilepsyUnited States, United Kingdom, Argentina, Canada, Greece, Italy, Spain
-
UCB Pharma SACompletedEpilepsy, PartialCanada, United States
-
Supernus Pharmaceuticals, Inc.CompletedSafety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyPartial EpilepsyUnited States, Poland, Bulgaria, Romania, Canada, Russian Federation, Mexico, Croatia
-
Xenon Pharmaceuticals Inc.Worldwide Clinical TrialsEnrolling by invitationFocal Epilepsy | Tonic-Clonic SeizuresSpain, United States, Canada, Poland
-
UCB PharmaCompletedEpilepsy, PartialUnited States, South Africa, Canada
-
Supernus Pharmaceuticals, Inc.ParexelCompletedEpilepsies, PartialUnited States, Poland, Mexico, Bulgaria, Romania, Canada, Russian Federation, Croatia
-
Eisai Inc.CompletedEpilepsy, Complex PartialUnited States, Estonia, Ukraine, Hungary, Lithuania
-
PfizerCompletedSeizure Disorder, PartialAustralia, Spain, Portugal, United Kingdom, Canada, Belgium, Germany, Poland, Netherlands, Austria
-
SunovionCompletedEpilepsyUnited States, Bulgaria, Czech Republic, Serbia, Ukraine
-
UCB PharmaCompletedEpilepsy, PartialUnited States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
-
SK Life Science, Inc.CompletedPartial EpilepsyUnited States, Spain, Korea, Republic of, Serbia, Germany, Bulgaria, Argentina, Australia, Chile, Czechia, Hungary, Mexico, Poland, Russian Federation, Sweden, Thailand, Ukraine
-
PfizerCompletedEpilepsies, Partial | Epilepsy, Complex PartialSpain, France, Canada, Germany, Italy, Lithuania, Austria, United Kingdom